Global Depression Treatment Therapy Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Depression Treatment Therapy Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Depression Therapy and Treatment market refers to the market for treatment of depression conditions through several techniques such as psychodynamic therapy, interpersonal therapy, and cognitive behavioural therapy.

Market Overview:

The latest research study on the global Depression Treatment Therapy market finds that the global Depression Treatment Therapy market reached a value of USD 13055.06 million in 2022. It’s expected that the market will achieve USD 15789.0 million by 2028, exhibiting a CAGR of 3.22% during the forecast period.

Increased use in young patients

Depression patients are the most common among adolescents and young people. Depression is the number one cause of death among people aged 15-34. At the same time, patients with depression have tended to become younger in recent years. Whether it is medication or other treatments, they have a tendency to lean towards lower-collar patients.

Depression market shrinks significantly

The main reasons for this are Zoloft (sertraline), Paxil / Paxil CR (paroxetine), Effexor / Effexor XR (venlafaxine), Celexa (citalopram), Brand medicines such as Wellbutrin / Wellbutrin SR / Wellbutrin XR (bupropion), Lexapro (Edipram), Prozac (fluoxetine) and Remeron (mirtazapine) have suffered severe market contraction due to patent failure due to generic competition. Patent expiry and generic drug manufacturers obtaining manufacturer licenses are forcing many brand drug manufacturers to either halt R & D or reduce budgets. The number of new drugs under development is very limited. The main reason for the decline in income is that prices of once expensive medicines have fallen by more than 50-90%. Due to the decline in revenue, the market's research and development momentum is blocked, which is not conducive to the healthy development of the market.

Region Overview:

In global comparison, a significant portion of the revenue was generated in Americas (51.68% in 2022).

Company Overview:

Pfizer is one of the major players operating in the Depression Treatment Therapy market, holding a share of 9.76% in 2023.

Pfizer

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Eli Lily

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.

Segmentation Overview:

Among different product types, Drugs segment is anticipated to contribute the largest market share in 2028.

Application Overview:

In the Depression Treatment Therapy market, 35.59% of the total value was generated through the Major Depression segment by application in 2022.

Key Companies in the global Depression Treatment Therapy market covered in Chapter 3:

Eli Lily
Teva Pharmaceutical
Takeda
AstraZeneca
Otsuka Pharmaceutical
Sanofi
Merck
Novartis
Allergan
Lundbeck
Johnson and Johnson
Pfizer

In Chapter 4 and Chapter 14.2, on the basis of types, the Depression Treatment Therapy market from 2018 to 2029 is primarily split into:

Drugs
Treatment Device

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Depression Treatment Therapy market from 2018 to 2029 covers:

Seasonal Affective Disorder (SAD)
Major Depression
Dysthymia Disorder
Postpartum Depression
Atypical Depression
Psychotic Depression
Bipolar Disorder

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)